Podofilotoksyna (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Podofilotoksyna" in Polish language version.

refsWebsite

Global rank Polish rank

6doi.org

2^nd place

6^th place

5nih.gov

4^th place

7^th place

1drugbank.ca

4,294^th place

205^th place

1aacrjournals.org

8,869^th place

9,541^st place

aacrjournals.org

TeruhiroT. Utsugi TeruhiroT. i inni, Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer, „Cancer Research”, 56 (12), 1996, s. 2809–2814, PMID: 8665518 [dostęp 2024-07-01] (ang.).

doi.org

dx.doi.org

ZinniaZ. Shah ZinniaZ. i inni, Podophyllotoxin: History, Recent Advances and Future Prospects, „Biomolecules”, 11 (4), 2021, s. 603, DOI: 10.3390/biom11040603 [dostęp 2024-07-01] (ang.).
Popat S.P.S. Kumbhar Popat S.P.S. i inni, Podophyllotoxin-polyacrylic acid conjugate micelles: improved anticancer efficacy against multidrug-resistant breast cancer, „Journal of the Egyptian National Cancer Institute”, 32 (1), 2020, DOI: 10.1186/s43046-020-00053-1 [dostęp 2024-07-01] (ang.).
WeiW. Zhao WeiW. i inni, Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy, „Natural Product Reports”, 38 (3), 2021, s. 470–488, DOI: 10.1039/D0NP00041H, PMID: 32895676 [dostęp 2024-07-01] (ang.).
YoungjaeY. You YoungjaeY., Podophyllotoxin Derivatives: Current Synthetic Approaches for New Anticancer Agents, „Current Pharmaceutical Design”, 11 (13), s. 1695–1717, DOI: 10.2174/1381612053764724, PMID: 15892669 [dostęp 2024-07-01] (ang.).
Tze‐SingT.‐S. Huang Tze‐SingT.‐S. i inni, A Novel Podophyllotoxin-Derived Compound GL331 Is More Potent than Its Congener VP-16 in Killing Refractory Cancer Cells, „Pharmaceutical Research”, 16 (7), 1999, s. 997–1002, DOI: 10.1023/A:1018971313256, PMID: 10450922 [dostęp 2024-07-01] (ang.).
A.-R.A.R. Hanauske A.-R.A.R. i inni, Activity of NK 611, a new epipodophyllotoxin derivative, against colony forming units from freshly explanted human tumours in vitro, „European Journal of Cancer”, 31 (10), 1995, s. 1677–1681, DOI: 10.1016/0959-8049(95)00245-E, PMID: 7488424 [dostęp 2024-07-01] (ang.).

drugbank.ca

Podofilox, [w:] DrugBank [online], University of Alberta, DB01179 [dostęp 2024-07-01] (ang.).

nih.gov

ncbi.nlm.nih.gov

WeiW. Zhao WeiW. i inni, Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy, „Natural Product Reports”, 38 (3), 2021, s. 470–488, DOI: 10.1039/D0NP00041H, PMID: 32895676 [dostęp 2024-07-01] (ang.).
YoungjaeY. You YoungjaeY., Podophyllotoxin Derivatives: Current Synthetic Approaches for New Anticancer Agents, „Current Pharmaceutical Design”, 11 (13), s. 1695–1717, DOI: 10.2174/1381612053764724, PMID: 15892669 [dostęp 2024-07-01] (ang.).
Tze‐SingT.‐S. Huang Tze‐SingT.‐S. i inni, A Novel Podophyllotoxin-Derived Compound GL331 Is More Potent than Its Congener VP-16 in Killing Refractory Cancer Cells, „Pharmaceutical Research”, 16 (7), 1999, s. 997–1002, DOI: 10.1023/A:1018971313256, PMID: 10450922 [dostęp 2024-07-01] (ang.).
TeruhiroT. Utsugi TeruhiroT. i inni, Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer, „Cancer Research”, 56 (12), 1996, s. 2809–2814, PMID: 8665518 [dostęp 2024-07-01] (ang.).
A.-R.A.R. Hanauske A.-R.A.R. i inni, Activity of NK 611, a new epipodophyllotoxin derivative, against colony forming units from freshly explanted human tumours in vitro, „European Journal of Cancer”, 31 (10), 1995, s. 1677–1681, DOI: 10.1016/0959-8049(95)00245-E, PMID: 7488424 [dostęp 2024-07-01] (ang.).